Tango Therapeutics, Inc. ( TNGX) - Stock Earnings
TNGX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 11, 2026, midnight | — / — | — | — / — | — |
TNGX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -38.7 million USD | — USD |
| 2026Q1 | -45.5 million USD | — USD |
| 2026Q2 | -55.3 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
TNGX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -101.7 million USD | 36.5 million USD |
| 2024 | -130.3 million USD | 42.1 million USD |
| 2025 | -101.6 million USD | 62.4 million USD |
| 2026 Est. | — | — |
TNGX
Price: $25.60
52 week price:
Earnings Per Share: -0.82 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 179400
Market Capitalization: 4.3 billion